How many acquisitions has Teva Pharmaceuticals made so far?

Teva Pharmaceuticals has completed 20 acquisitions so far, with an average acquisition amount of $4.8B.

Which countries does Teva Pharmaceuticals usually acquire in?

Teva Pharmaceuticals has made acquisitions in 7 countries with the most activity in United States and Belgium.

Which is Teva Pharmaceuticals' latest acquisition?

Teva Pharmaceuticals's most recent acquisition is Emalex Biosciences, a Developer of therapeutics for the treatment of rare and orphan neurological conditions, acquired in April 2026.

In which year did Teva Pharmaceuticals make the most acquisitions?

Teva Pharmaceuticals was most active in 2015, with 5 acquisitions completed in that year.

List of 20 Acquisitions by Teva Pharmaceuticals (Oct 2026)

Most viewed in 2019

Teva Pharmaceuticals has made a total of 20 acquisitions. These transactions span 11 sectors, including Neurology, Women Health, and Pain Management, across 7 countries, such as United States, Belgium, and Japan. Peak activity occurred in 2015 with 5 acquisitions, 2013 with 3 acquisitions, and 2016 with 2 acquisitions. During the 2020–2025 period, it recorded an average of 1.2 acquisitions per year and has completed 1 acquisition so far this year. In April 2026, it acquired Emalex Biosciences, a Northbrook-based developer of therapeutics for rare and orphan neurological conditions founded in 2018.

Here's the year on year acquisition history of Teva Pharmaceuticals:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2016	2
2015	5
2014	2
2013	3
2011	2
2008	2
2006	1
2004	1
2003	1

View all Acquisitions by Teva Pharmaceuticals

Recent acquisitions by Teva Pharmaceuticals

Teva Pharmaceuticals's most recent acquisition - Emalex Biosciences is a Developer of therapeutics for the treatment of rare and orphan neurological conditions, founded in 2018 and located in Northbrook. Teva Pharmaceuticals acquired it in April 2026 for a price of $*****.

Here is the list of all acquisitions by Teva Pharmaceuticals sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Apr 29, 2026	Emalex Biosciences	yphj	uzag	78	620
Aug 03, 2016	Anda	mgyo	kaxn	13	861
Aug 03, 2016	Actavis	cjeb	bhtm	91	102
Oct 01, 2015	Rimsa Laboratories	ront	sbsr	82	737
Oct 01, 2015	rimsa	xwk{	sxsz	33	214